IP Verse

Pharmaceutical Composition Comprising Hmg Coa Reductase Inhibitors And Fenofibrate - EP3833335

PATENT ANALYSIS

Patent Details

Grant Date
Aug 31, 2022
Company
INTAS PHARMACEUTICALS LTD.
Oppositions

ELKINGTON AND FIFE LLP

VIATRIS HEALTHCARE LDA

More patents of Intas Pharmaceuticals Ltd.

EP3833335

EP2978426

Want to monitor this patent?

Feel free to send us a message here and we will get back to you